Portfolio Holdings Detail for ISIN IE00B3ZW0K18

Stock Name / Fund	iShares S&P 500 EUR Hedged UCITS ETF (Acc)
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	IBCF(EUR) F
ETF Ticker	IUES.AS(EUR) CXE
ETF Ticker	IUSE.L(EUR) CXE
ETF Ticker	IUSE.MI(EUR) CXE
ETF Ticker	IUSEz(EUR) CXE
ETF Ticker	IUSE(EUR) ETF Plus

Holdings detail for DXCM

Show aggregate DXCM holdings

News associated with DXCM

Implied QQEW Analyst Target Price: $156

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 07:55:44

Friday's ETF with Unusual Volume: QQH

The HCM Defender 100 Index ETF is seeing unusually high volume in afternoon trading Friday, with over 190,000 shares traded versus three month average volume of about 26,000. Shares of QQH were up about 0.6% on the day. Components of that ETF with the highest volume on Friday - 2025-09-19 13:23:32

Nasdaq 100 Movers: DXCM, FTNT

In early trading on Friday, shares of Fortinet topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.7%. Year to date, Fortinet has lost about 11.9% of its value. And the worst performing Nasdaq 100 component thus far on the day is DexCo - 2025-09-19 12:11:42

DexCom, Inc. (NASDAQ:DXCM) Receives $99.89 Consensus Price Target from Brokerages

Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-two analysts that are presently covering the company, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation, fourteen have given a buy recommendation and three have given a strong buy […] - 2025-09-18 03:01:05

Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside

When it comes to identifying target stocks for investment, compelling prospects may include companies that are undervalued and, simultaneously, expected to appreciate in the future. Of course, timing an investment in one of these firms is notoriously difficult. It may help to lo - 2025-09-14 11:27:00

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 13:38:14

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 12:43:18

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 12:13:06

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 10:36:17

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 08:39:38

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 08:27:13

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 06:09:22

DexCom (NASDAQ:DXCM) Downgraded by Oppenheimer to Market Perform

Oppenheimer cut shares of DexCom (NASDAQ:DXCM – Free Report) from an outperform rating to a market perform rating in a research report sent to investors on Monday, MarketBeat.com reports. Other research analysts have also recently issued research reports about the stock. Argus assumed coverage on shares of DexCom in a research report on Thursday, August […] - 2025-09-09 02:50:44

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-08 22:27:11

DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Recommendation of “Moderate Buy” from Analysts

DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has been assigned an average rating of “Moderate Buy” from the twenty-two analysts that are presently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have issued a strong buy rating on […] - 2025-08-21 02:41:01

Leerink Partnrs Predicts DexCom’s Q3 Earnings (NASDAQ:DXCM)

DexCom, Inc. (NASDAQ:DXCM – Free Report) – Investment analysts at Leerink Partnrs dropped their Q3 2025 earnings estimates for shares of DexCom in a report released on Wednesday, July 30th. Leerink Partnrs analyst M. Kratky now expects that the medical device company will post earnings of $0.57 per share for the quarter, down from their […] - 2025-08-04 02:46:55

DexCom (DXCM) Q2 Revenue Jumps 15%

Key PointsRevenue (GAAP) rose 15% year-over-year in Q2 2025, easily surpassing expectations and driven by strong U.S. and international growth. - 2025-08-01 01:53:01

Allianz Asset Management GmbH Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM)

Allianz Asset Management GmbH lowered its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 22.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 73,079 shares of the medical device company’s stock after selling 21,698 shares during the period. Allianz Asset […] - 2025-07-29 04:42:53

DexCom (DXCM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

Besides Wall Street's top-and-bottom-line estimates for DexCom (DXCM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025. - 2025-07-29 01:00:16

Private Advisor Group LLC Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM)

Private Advisor Group LLC cut its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 11.1% during the 1st quarter, HoldingsChannel.com reports. The fund owned 13,461 shares of the medical device company’s stock after selling 1,688 shares during the period. Private Advisor Group LLC’s holdings in DexCom were worth $919,000 as of its most recent […] - 2025-07-28 05:22:58

HighPoint Advisor Group LLC Has $299,000 Holdings in DexCom, Inc. (NASDAQ:DXCM)

HighPoint Advisor Group LLC cut its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 15.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,196 shares of the medical device company’s stock after selling 749 shares during the quarter. HighPoint Advisor Group LLC’s […] - 2025-07-24 05:51:13

AVLV's Underlying Holdings Imply 10% Gain Potential

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-21 10:15:07

DexCom (NASDAQ:DXCM) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a research report report published on Friday. A number of other equities research analysts have also commented on the company. Cfra Research upgraded DexCom to a “hold” rating in a research report on Friday, March […] - 2025-07-21 04:58:50

Morgan Stanley Forecasts Strong Price Appreciation for DexCom (NASDAQ:DXCM) Stock

DexCom (NASDAQ:DXCM – Get Free Report) had its target price increased by equities research analysts at Morgan Stanley from $82.00 to $89.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the medical device company’s stock. Morgan Stanley’s price objective would indicate a potential upside […] - 2025-07-17 06:22:53

Cerity Partners LLC Grows Stock Holdings in DexCom, Inc. (NASDAQ:DXCM)

Cerity Partners LLC grew its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 4.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 69,601 shares of the medical device company’s stock after acquiring an additional 2,711 shares during the period. Cerity Partners LLC’s […] - 2025-07-17 05:30:58

DexCom, Inc. (NASDAQ:DXCM) Shares Acquired by Stratos Wealth Partners LTD.

Stratos Wealth Partners LTD. increased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 32.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,428 shares of the medical device company’s stock after buying an additional 845 shares during the quarter. Stratos […] - 2025-07-17 04:58:54

Allworth Financial LP Purchases 1,765 Shares of DexCom, Inc. (NASDAQ:DXCM)

Allworth Financial LP lifted its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 163.3% during the 1st quarter, Holdings Channel reports. The firm owned 2,846 shares of the medical device company’s stock after acquiring an additional 1,765 shares during the period. Allworth Financial LP’s holdings in DexCom were worth $201,000 at the end of […] - 2025-07-16 05:18:51

Nisa Investment Advisors LLC Cuts Stake in DexCom, Inc. (NASDAQ:DXCM)

Nisa Investment Advisors LLC lowered its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 53.9% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 34,228 shares of the medical device company’s stock after selling 40,004 shares during the quarter. Nisa Investment Advisors […] - 2025-07-14 05:50:57

Principal Financial Group Inc. Boosts Holdings in DexCom, Inc. (NASDAQ:DXCM)

Principal Financial Group Inc. lifted its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 804,917 shares of the medical device company’s stock after purchasing an additional 219,965 shares during the […] - 2025-07-07 08:08:45

First Horizon Advisors Inc. Has $108,000 Stock Position in DexCom, Inc. (NASDAQ:DXCM)

First Horizon Advisors Inc. increased its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 25.4% during the 1st quarter, Holdings Channel.com reports. The fund owned 1,582 shares of the medical device company’s stock after acquiring an additional 320 shares during the period. First Horizon Advisors Inc.’s holdings in DexCom were worth $108,000 […] - 2025-07-07 06:19:27

iShares S&P 500 EUR Hedged UCITS ETF (Acc) DXCM holdings

Date	Number of DXCM Shares Held	Base Market Value of DXCM Shares	Local Market Value of DXCM Shares	Change in DXCM Shares Held	Change in DXCM Base Value	Current Price per DXCM Share Held	Previous Price per DXCM Share Held
2025-09-30 (Tuesday)	62,315	USD 3,568,661	USD 3,568,661	-188	USD 27,357	USD 57.2681	USD 56.6581
2025-09-29 (Monday)	62,503	USD 3,541,304	USD 3,541,304	0	USD -45,722	USD 56.6581	USD 57.3897
2025-09-26 (Friday)	62,503	USD 3,587,026	USD 3,587,026	0	USD -68,997	USD 57.3897	USD 58.4936
2025-09-25 (Thursday)	62,503	USD 3,656,023	USD 3,656,023	0	USD 63,438	USD 58.4936	USD 57.4786
2025-09-24 (Wednesday)	62,503	USD 3,592,585	USD 3,592,585
2025-09-18 (Thursday)	62,503	USD 4,022,144	USD 4,022,144	0	USD -9,695	USD 64.3512	USD 64.5063
2025-09-17 (Wednesday)	62,503	USD 4,031,839	USD 4,031,839	0	USD -5,121	USD 64.5063	USD 64.5883
2025-09-16 (Tuesday)	62,503	USD 4,036,960	USD 4,036,960	94	USD 25,332	USD 64.5883	USD 64.2796
2025-09-15 (Monday)	62,409	USD 4,011,628	USD 4,011,628	94	USD -38,555	USD 64.2796	USD 64.9953

Share Trades of DXCM by Blackrock for IE00B3ZW0K18

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-09-30	SELL	-188			57.268*		71.83 Profit of 13,503 on sale
2025-09-16	BUY	94			64.588*		72.17
2025-09-15	BUY	94			64.280*		72.21
2025-08-21	BUY	92			69.401*		72.31
2025-08-20	SELL	-184			70.025*		72.32 Profit of 13,308 on sale
2025-08-13	BUY	184			68.228*		72.37
2025-08-12	BUY	92			68.765*		72.39
2025-08-08	SELL	-92			67.656*		72.44 Profit of 6,665 on sale
2025-08-05	BUY	184			65.243*		72.52
2025-08-04	SELL	-364			65.935*		72.56 Profit of 26,411 on sale
2025-08-01	SELL	-91			68.614*		72.58 Profit of 6,605 on sale
2025-07-31	BUY	270			70.569*		72.59
2025-07-30	BUY	90			77.578*		72.56
2025-07-18	SELL	-273			72.024*		72.53 Profit of 19,800 on sale
2025-07-16	SELL	-182			72.548*		72.53 Profit of 13,200 on sale
2025-07-10	BUY	91			73.165*		72.52
2025-07-07	BUY	182			70.656*		72.54
2025-07-02	BUY	91			71.026*		72.58
2025-06-24	BUY	182			75.381*		72.56
2025-06-23	BUY	91			69.242*		72.58
2025-06-18	BUY	91			70.391*		72.63
2025-06-17	BUY	91			70.990*		72.64
2025-06-05	SELL	-180			74.833*		72.60 Profit of 13,069 on sale
2025-06-03	BUY	180			76.182*		72.56
2025-05-28	BUY	1,012			76.960*		72.47
2025-05-27	BUY	276			75.237*		72.45
2025-05-22	SELL	-92			75.214*		72.40 Profit of 6,661 on sale
2025-05-21	SELL	-92			74.852*		72.38 Profit of 6,659 on sale
2025-05-20	SELL	-184			77.508*		72.34 Profit of 13,310 on sale
2025-05-19	SELL	-184			77.274*		72.30 Profit of 13,303 on sale
2025-05-15	BUY	92			76.580*		72.23
2025-05-14	BUY	184			77.157*		72.19
2025-05-13	BUY	276			75.351*		72.16
2025-05-12	BUY	552			76.539*		72.13
2025-05-09	BUY	276			75.139*		72.10
2025-05-02	BUY	92			71.792*		72.07
2025-04-30	BUY	5,839			62.793*		72.25
2025-04-28	BUY	83			62.554*		72.42
2025-04-25	SELL	-83			63.034*		72.51 Profit of 6,018 on sale
2025-04-24	BUY	249			62.232*		72.60
2025-04-23	BUY	83			58.908*		72.73
2025-04-22	BUY	83			57.789*		72.87
2025-04-16	SELL	-83			60.382*		73.39 Profit of 6,091 on sale
2025-04-15	BUY	83			61.114*		73.51
2025-04-14	BUY	166			59.283*		73.65
2025-04-11	BUY	166			58.332*		73.81
2025-04-10	BUY	83			60.194*		73.95
2025-04-09	BUY	83			60.552*		74.08
2025-04-08	BUY	166			55.623*		74.28
2025-04-07	SELL	-83			56.425*		74.46 Profit of 6,181 on sale
2025-04-04	SELL	-501			54.448*		74.68 Profit of 37,413 on sale
2025-04-01	SELL	-166			62.273*		74.94 Profit of 12,440 on sale
2025-03-31	SELL	-164			63.220*		75.07 Profit of 12,311 on sale
2025-03-28	SELL	-164			62.589*		75.21 Profit of 12,334 on sale
2025-03-25	BUY	82			68.099*		75.51
2025-03-21	SELL	-324			68.276*		75.66 Profit of 24,515 on sale
2025-03-20	SELL	-243			69.245*		75.74 Profit of 18,405 on sale
2025-03-18	BUY	492			64.702*		75.98
2025-03-11	SELL	-82			64.299*		76.72 Profit of 6,291 on sale
2025-03-10	SELL	-243			65.255*		76.87 Profit of 18,680 on sale
2025-03-07	SELL	-567			71.610*		76.94 Profit of 43,626 on sale
2025-03-05	SELL	-243			76.143*		76.95 Profit of 18,699 on sale
2025-03-03	SELL	-324			82.009*		76.86 Profit of 24,904 on sale
2025-02-27	SELL	-81			84.327*		76.64 Profit of 6,208 on sale
2025-02-19	BUY	81			86.032*		75.82
2025-02-18	BUY	162			86.491*		75.65
2025-02-13	BUY	164			80.596*		75.26
2025-02-05	SELL	-656			85.189*		74.26 Profit of 48,713 on sale
2025-02-04	BUY	82			84.254*		74.07
2025-01-29	BUY	82			82.946*		73.28
2025-01-28	BUY	82			84.752*		73.04
2025-01-24	BUY	246			84.379*		72.57
2025-01-23	BUY	574			84.347*		72.31
2025-01-22	BUY	410			83.584*		72.05
2025-01-21	BUY	82			82.996*		71.80
2025-01-16	BUY	492			82.365*		71.05
2025-01-15	BUY	82			78.017*		70.87
2025-01-10	BUY	82			75.867*		70.36
2024-12-10	BUY	82			75.596*		69.75
2024-12-09	BUY	328			74.028*		69.62
2024-12-05	SELL	-164			74.639*		69.32 Profit of 11,368 on sale
2024-12-04	BUY	246			76.936*		69.06
2024-12-03	SELL	-410			76.929*		68.77 Profit of 28,198 on sale
2024-12-02	BUY	164			75.753*		68.52
2024-11-25	BUY	162			74.205*		67.26
2024-11-22	SELL	-81			69.962*		67.13 Profit of 5,437 on sale
2024-11-21	SELL	-81			70.840*		66.94 Profit of 5,422 on sale
2024-11-18	BUY	405			72.133*		66.14
2024-11-12	BUY	81			70.069*		65.90
2024-11-08	BUY	567			65.085*		65.95
2024-11-07	BUY	162			63.735*		66.12
2024-11-06	BUY	81			63.892*		66.30
2024-10-31	SELL	-5,354			64.920*		67.33 Profit of 360,488 on sale
2024-10-29	BUY	92			66.898*		67.61
2024-10-28	BUY	92			66.645*		67.80
2024-10-25	BUY	92			67.802*		67.80
2024-10-24	BUY	92			69.322*		67.30
2024-10-23	SELL	-184			67.267*		67.31 Profit of 12,385 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of DXCM

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer